CAU Scholar's Space: Jung, Sun-Young

Detailed Information

Jung, Sun-Young (정선영)

대학원 (글로벌혁신신약학과)

Research Area

Tel 02-820-5678
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Osteoarthritis:7||COVID19:6||Epidemiology:4||Elderly:3||Mortality:3||Pharmacoepidemiology:3||ischemic stroke:3||Pharmacovigilance:3||Adverse events:3||Knee:3||Regulatory science:2||Fallrelated injuries:2||Malignancy:2||Fracture:2||약물감시:2||nonsteroidal:2||약물역학:2||Incidence:2||Older adults:2||chronic obstructive:2||Systemic lupus erythematosus:2||SARSCoV2:2||survey:2||comorbidity:2||Corticosteroids:2||pharmacoepidemiology:2||Therapeutics:2||incidence:2||Thiamine:2||training project:2||tramadol:2||Sepsis:2||Treatment:2||Septic shock:2||Ascorbic acid:2||Pulmonary disease:2||Drugrelated side effects and adverse reactions:2||Antidepressants:2||Brighton Collaboration:1||Bronchoscopy:1||COX Inhibitor:1||Cardiac surgical procedures:1||Cardiomyopathies:1||Cardiovascular adverse events:1||Cardiovascular diseases:1||Case–control:1||Casecrossover:1||Casecrossover design:1||Cataract:1||Change point analysis:1||Cholinergic antagonist:1||Cholinesterase inhibitors:1||Chronic pain:1||Claims database:1||Clinical alarms:1||Clinical trials:1||Cluster:1||Cohort study:1||Comorbidity:1||Concurrent medications:1||Concurrent use:1||Congestive heart failure:1||Corticosteroid:1||Costeffectiveness:1||Counterfeit medicine:1||Cyclosporine:1||Cynanchi wilfordii Radix:1||Data mining:1||Dementia:1||Dementia, Alzheimer type:1||Depression:1||Diabetes mellitus:1||Diagnosis:1||Drug interactions:1||Drug prescriptions:1||Drug pricing system:1||Drug utilization:1||Drug utilization evaluation:1||Drug utilization patterns:1||Drug utilization review:1||Ecigarette:1||Effectiveness:1||Emergency contraceptive pills:1||Endstage renal disease:1||Enteritis:1||Eradication:1||Etoricoxib:1||Fall riskincreasing drugs:1||GMP:1||GuillainBarre:1||GuillainBarre syndrome:1||Halflife:1||Health Expenditure:1||Health insurance claims database:1||Health services research:1||Healthcare Administrative Claims:1||Helicobacter pylori:1||Hemorrhages:1||Hip fractures:1||Hospitalization:1||Households:1||Human papilloma virus vaccines:1||Hydrocortisone:1||Hydroxychloroquine:1||Hypersensitivity Pneumonitis:1||Hypertension:1||IMI:1||Idiopathic inflammatory myopathy:1||Idiopathic inflammatory myositis:1||Incidence rate:1||Inflammatory Myopathy:1||Injection:1||Innovation:1||Insurance claims data:1||Intensive care units:1||International Medical Products Anti‐Counterfeiting Taskforce:1||Ischemic stroke:1||Janus kinase inhibitor:1||KIDSKAERS database:1||KIDSKD:1||Korea Institute of Drug Safety and Risk Management:1||Korea/epidemiology:1||Latent class analysis:1||Low dose:1||Lung neoplasm:1||Lupus nephritis:1||MAPK pathway:1||MFDS:1||Medical Management:1||Medication persistence:1||Multidrug resistant tuberculosis:1||Myocardial infarction:1||Myocarditis:1||NFkappa B:1||NFkappa B pathway:1||NHISNSC:1||Nationwide study:1||Neoplasm:1||Nested casecontrol study:1||Nicotine Dependence:1||Nonsteroidal antiinflammatory drugs (NSAIDs):1||Nontuberculous mycobacteria:1||Nonvitamin K antagonist oral anticoagulants:1||Nonsteroidal Antiinflammatory Drugs:1||Nonsteroidal antiinflammatory drugs:1||Operational Definition:1||Opioids:1||Oral contraceptive pills:1||Outbreak:1||Parkinson's disease:1||Patent:1||Patterns and trends:1||Pharamcoepidemiology:1||Pharmaceutical industry:1||Pneumonia:1||Polypharmacy:1||Polyphenol:1||Population surveillance:1||Preexposure prophylaxis:1||Prescription patterns:1||Presynaptic terminal:1||Prevalence:1||Prunus persica L:1||Publication:1||Publication bias:1||Quality improvements:1||Rapid Alert System:1||Rapid response team:1||Regulations:1||Renal prognosis:1||Reporting:1||Research Design:1||Resuscitation:1||Retrospective cohort study:1||Rheumatic diseases:1||Rheumatoid Arthritis:1||Rheumatoid arthritis:1||Risk management:1||Rotavirus:1||SJS:1||Safety:1||Selfcontrolled caseseries analysis:1||Serious adverse event:1||Severe acute respiratory syndrome coronavirus 2:1||Sex:1||Signal detection:1||Smoking:1||Social impairment:1||South Korea:1||Spontaneous reporting system:1||Standardised incidence ratio:1||Steroid phobia:1||Steroids:1||StevensJohnson syndrome:1||Stress Susceptibility:1||Symptomatic slowacting drugs for osteoarthritis:1||Synapsin1:1||Systematic review:1||TEN:1||TMEM16A:1||The Korea National Health Insurance Service (NHIS) database:1||Time series:1||Toxic epidermal necrolysis:1||Traffic accidents:1||Trend:1||Trial registration:1||Tricyclic antidepressants:1||Tuberculosis:1||Tumour necrosis factor inhibitor:1||Type 2 angiotensin receptor antagonists:1||Vaccination:1||Vaccine:1||Vaccines:1||Venous thromboembolism:1||Venous thrombosis:1||VigiBase:1||Vitamin B 12:1||Waist circumference:1||World Health Organization:1||acetaminophen:1||administrative claims:1||advanced biopharmaceutical:1||adverse drug reactions:1||adverse event:1||adverse event following immunization:1||adverse reactions:1||ageing:1||alphaadrenoceptor antagonist:1||alveolar bone loss:1||analgesics:1||angiotensin II receptor blocker:1||antiinflammatory agents:1||antiinflammatory effect:1||anticoagulants:1||antihypertensives:1||ascorbic acid:1||asthma:1||atrial fibrillation:1||betablocker:1||betablockers:1||bisphosphonate:1||bisphosphonateassociated osteonecrosis of the jaw:1||body mass index:1||calcium channel blocker:1||cancer surgery:1||casecontrol study:1||casecrossover:1||causality assessment:1||chronic obstructive pulmonary disease:1||claims data:1||community pharmacy:1||comprehension:1||contraindicated comedications:1||costs:1||critical care:1||dementia:1||dermatomyositis:1||diabetes:1||diagnostic codes:1||drug induced lung disease:1||drug safety:1||drug therapy:1||drug utilization review:1||drugdrug interactions:1||drugrelated side effects and adverse reactions:1||duplication:1||dyslipidemias:1||education and training:1||extracorporeal membrane oxygenation:1||fixeddose combination drugs:1||general anesthesia:1||geriatrics:1||glial cells:1||guideline:1||health behaviours:1||health literacy:1||hematologic malignancy:1||hemorrhage:1||hospitalization:1||human papilloma virus:1||hydrocortisone:1||illegally obtained prescription drugs:1||immune system:1||influenza vaccine:1||influenzalike illness:1||inhalation anesthesia:1||innovative medicines initiative:1||intensive care unit:1||logistic regression model:1||long term followup:1||low back pain:1||mRNA vaccine:1||medical products:1||medical utilization:1||medication:1||medication adherence:1||medication compliance:1||medication errors:1||monitoring:1||myopathy:1||myositis:1||national health insurance claims database:1||nonprescription:1||opioid analgesics:1||opioids:1||osteoarthritis:1||osteonecrosis of the jaw:1||patient safety:1||patient safety culture:1||pharmaceutical labeling:1||pharmacovigilance:1||phosphodiesterase type 5 inhibitors:1||pictogram:1||polymyositis:1||precision:1||primary Sjogren's syndrome:1||proinflammatory mediators:1||propofol:1||realworld setting:1||recall:1||registry:1||regulatory science education:1||reninangiotensin system:1||respiratory disease:1||retrospective studies:1||rheumatoid arthritis:1||safety:1||safety regulation:1||safety signal detection:1||seasonal influenza:1||sedatives:1||selfcontrolled case series:1||septic shock:1||serious outcomes:1||seropositivity:1||serotonin:1||signal detection:1||solid malignancy:1||statins:1||steroids:1||survival:1||syndrome:1||systematic review:1||telephone survey:1||therapeutic duplication:1||thiamine:1||thiazide diuretic:1||topical corticosteroid:1||vaccine:1||validation:1||ventilators (mechanical):1||weight change:1||계절성 인플루엔자:1||급성심근경색증:1||노인:1||로지스틱 회귀모형:1||마약성 진통제:1||빅데이터:1||사용양상:1||사전경구피임제:1||사후경구피임제:1||세계보건기구:1||수신자 조작 특성 곡선:1||신속경고시스템:1||안전성:1||약물사용평가:1||약물상호반응:1||위조의약품:1||위해관리:1||유해사례:1||인플루엔자 의사환자:1||재현율:1||전화설문:1||정확도:1||중환자실:1||코르티코스테로이드:1||코호트 연구:1||표본코호트DB:1||ACE inhibitor:1||호흡기 질환:1||ACEI/ARB:1||AUROC:1||Acetylcholinesterase inhibitor:1||Acute exacerbation:1||Acute myocardial infarction:1||Advanced breast cancer:1||Adverse drug reaction:1||Adverse events.:1||Aged:1||Ambulatory analgesics:1||Angiotensinconverting enzyme antagonists:1||Anoctamin1:1||Antiinflammatory agents:1||Antiinflammatory effect:1||Antibacterial activity:1||Antidepressant:1||Antidepressant. Benzodiazepine:1||Antioxidant activity:1||Arthritis, Rheumatoid:1||Asian:1||Asian Continental Ancestry Group:1||Aspirin:1||Asthma:1||Atrial fibrillation:1||Atypical antipsychotics:1||Autoimmune diseases:1||Awareness:1||Azathioprine:1||Batsch:1||Behavioral analysis:1||Benzodiazepines:1||Betaadrenergic blockers:1||Bias:1||Big data:1||Biologics:1||Biosimilar:1||Body mass index:1||

STATISTICS: Total View :6,922,809; Today View :2,047

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE